Biolab stands out as a pioneer of pharmaceutical innovation in Brazil, with achievements that reflect our commitment to health and scientific advancement.
Find out more about our initiatives:
We have one of the largest cases of success and payment of royalties in partnership with universities.
VONAU FLASH®
Developed in partnership with the University of São Paulo (USP)*, Vonau Flash® is an innovative medicine for treating motion sickness. Its formulation allows the tablet to dissolve quickly in the mouth, which provides accelerated relief.
*INSTITUTIONAL AND NON-PROMOTIONAL/ADVERTISING MATERIAL.
PHOTOPROT®
The result of a joint project with the Federal University of Rio Grande do Sul (UFRGS), Photoprot® is a photoprotector with a sun protection factor of 99 (SPF 99) that uses nanotechnology in its formula.
Biolab also plays an active role in promoting national scientific research. Since 2009, we have sponsored the José Ribeiro do Valle Young Investigator Award, presented annually at the Brazilian Congress of Pharmacology and Experimental Therapeutics.
Collaboration with startups is key to driving continuous innovation and bringing dynamic, adaptable solutions to new healthcare challenges. This partnership allows us to integrate cutting-edge technologies with revolutionary ideas.
ANPEI - To strengthen our dedication to innovation and collaborate with influential companies and institutions in stimulating national innovation, we do part of the National Association for Research and Development of Innovative Companies (ANPEI).
MIT-ILP - Reinforcing our commitment to excellence in innovation and with the firm purpose of bringing the best to Brazil, we are now members of the Massachusetts Institute of Technology (MIT), through the MIT Industrial Liaison Program (ILP).